Which Emerging Trends Are Driving The Pharmaceutical Stability And Storage Services Market Toward $3.57 Billion By 2029?
Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors
What Is The Current Size And Growth Outlook For The Pharmaceutical Stability And Storage Services Market?
The market value of pharmaceutical stability and storage services has seen a robust rise in recent times. It is predicted to escalate from $2.66 billion in 2024 to $2.81 billion in 2025, with a compound annual growth rate (CAGR) of 5.8%. This upward trajectory during the historic period can be linked to factors such as the escalating demand for biologics, the growing number of chronic disease cases, progress in drug invention, the increasing intricacy of drug recipes, and an expansion in research and development within the pharmaceutical sector.
The market size for pharmaceutical stability and storage services is projected to experience robust growth in the coming years, expected to reach a size of “$3.57 billion in 2029” with a compound annual growth rate (CAGR) of 6.1%. This anticipated growth within the forecasted period can be linked to the growing popularity of personalized medicine, increased cold chain logistics, expansion of biopharma pipelines, surging approvals of biologic drugs, and an escalating demand for stability testing. Furthermore, the forecast period will see major trends such as technological progression, advancements in cryogenic storage technologies, evolution in digital monitoring technologies, breakthroughs in packaging technologies, and improved temperature-controlled storage systems.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23473&type=smp
What Core Drivers Are Expected To Influence The Pharmaceutical Stability And Storage Services Market?
The expected boost in the pharmaceutical stability and storage services market is likely to come from the increasing number of new drug approvals. These novel drugs are new pharmaceutical entities that haven’t been previously approved or marketed. The spike in novel drug approvals can be attributed to developments in biotechnology that allows for the creation of new compounds and improved regulatory methods that enable quicker and more effective drug production. The impact of more novel drug approvals results in a surge in need for pharmaceutical stability and storage services, which ensures the right conditions, adherence to regulations, and management of shelf-life. To illustrate, the U.S. Food and Drug Administration (FDA), the federal agency in the U.S. dedicated to maintaining public health, revealed in October 2023 that 37 novel drugs were approved by the FDA in 2022, and this increased to 50 in 2024. These novel drugs aided in advancing treatments for various diseases and disorders, including cancer, rare diseases, neurology-related conditions, infections, and diseases such as schizophrenia, pain, and Alzheimer’s. Hence, the expected growth of the pharmaceutical stability and storage services market is attributed to the rising number of novel drug approvals.
What Are The Main Segment Classifications In The Pharmaceutical Stability And Storage Services Market?
The pharmaceutical stability and storage services market covered in this report is segmented –
1) By Service: Stability, Storage
2) By Product Type: Tablets, Capsules, Injectable Solutions, Oral Suspensions, Combination Products, Other Product Types
3) By Molecule: Small Molecule, Large Molecule
4) By Mode: In-House, Outsourcing
5) By End User: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Other End Users
Subsegments:
1) Stability Services: Long-Term Stability Studies, Accelerated Stability Studies, Intermediate Stability Studies, Photostability Testing, Forced Degradation Studies
2) Storage Services: Ambient Storage, Refrigerated Storage (2°C to 8°C), Frozen Storage (-20°C to -80°C), Cryogenic Storage (-150°C to -196°C), Controlled Drug Substance And Product Storage
How Are Industry Trends Steering The Expansion Of The Pharmaceutical Stability And Storage Services Market?
Leading firms in the pharmaceutical stability and storage services sector are concentrating on developing state-of-the-art solutions, like cryogenic storage suites, to improve the conservation of temperature-sensitive pharmaceutical goods. Cryogenic storage suites are uniquely designed facilities that maintain extraordinarily low temperatures, generally below -150°C, to secure temperature-sensitive biological and pharmaceutical substances such as cell therapies, vaccines, and biologicals. For instance, in December 2024, Astoriom, a UK-based firm in the stability and biospecimen storage field, initiated a cryogenic storage suite at its Tramore site in County Waterford, Ireland, representing a notable broadening of its biological sample storage abilities. This cutting-edge suite is intended to satisfy the growing requirement for secure, long-term conservation of biological substances, assuring their survival over extended durations. The storage includes meticulous temperature management down to -196°C, large storage capability, ISO 9001 accreditation for regulatory compliance, and advanced safety features, involving access controls and surveillance systems.
Who Are The Major Stakeholders Operating In The Pharmaceutical Stability And Storage Services Market?
Major companies operating in the pharmaceutical stability and storage services market are Cencora Inc, SGS S.A., Eurofins Scientific SE, Catalent Inc, Charles River Laboratories, Intertek Group plc, Element Materials Technology Inc, Alloga UK Ltd., ALS Limited, Pharmaceutical Contract Industries Pharma Services., Almac Group, Alcami Corporation, BioLife Solutions Inc., Auriga Research Private Limited, Reading Scientific Services Ltd., Lucideon Limited, Q Laboratories Inc, PD Partners, Precision Stability Storage, Roylance Stability Storage Limited
Access The Complete Report Here:
What Are The Emerging Regional Trends Driving The Pharmaceutical Stability And Storage Services Market?
North America was the largest region in the pharmaceutical stability and storage services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical stability and storage services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=23473&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
